Cargando…

Breast cancer risk prediction in women aged 35–50 years: impact of including sex hormone concentrations in the Gail model

BACKGROUND: Models that accurately predict risk of breast cancer are needed to help younger women make decisions about when to begin screening. Premenopausal concentrations of circulating anti-Müllerian hormone (AMH), a biomarker of ovarian reserve, and testosterone have been positively associated w...

Descripción completa

Detalles Bibliográficos
Autores principales: Clendenen, Tess V., Ge, Wenzhen, Koenig, Karen L., Afanasyeva, Yelena, Agnoli, Claudia, Brinton, Louise A., Darvishian, Farbod, Dorgan, Joanne F., Eliassen, A. Heather, Falk, Roni T., Hallmans, Göran, Hankinson, Susan E., Hoffman-Bolton, Judith, Key, Timothy J., Krogh, Vittorio, Nichols, Hazel B., Sandler, Dale P., Schoemaker, Minouk J., Sluss, Patrick M., Sund, Malin, Swerdlow, Anthony J., Visvanathan, Kala, Zeleniuch-Jacquotte, Anne, Liu, Mengling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6425605/
https://www.ncbi.nlm.nih.gov/pubmed/30890167
http://dx.doi.org/10.1186/s13058-019-1126-z
_version_ 1783404870856867840
author Clendenen, Tess V.
Ge, Wenzhen
Koenig, Karen L.
Afanasyeva, Yelena
Agnoli, Claudia
Brinton, Louise A.
Darvishian, Farbod
Dorgan, Joanne F.
Eliassen, A. Heather
Falk, Roni T.
Hallmans, Göran
Hankinson, Susan E.
Hoffman-Bolton, Judith
Key, Timothy J.
Krogh, Vittorio
Nichols, Hazel B.
Sandler, Dale P.
Schoemaker, Minouk J.
Sluss, Patrick M.
Sund, Malin
Swerdlow, Anthony J.
Visvanathan, Kala
Zeleniuch-Jacquotte, Anne
Liu, Mengling
author_facet Clendenen, Tess V.
Ge, Wenzhen
Koenig, Karen L.
Afanasyeva, Yelena
Agnoli, Claudia
Brinton, Louise A.
Darvishian, Farbod
Dorgan, Joanne F.
Eliassen, A. Heather
Falk, Roni T.
Hallmans, Göran
Hankinson, Susan E.
Hoffman-Bolton, Judith
Key, Timothy J.
Krogh, Vittorio
Nichols, Hazel B.
Sandler, Dale P.
Schoemaker, Minouk J.
Sluss, Patrick M.
Sund, Malin
Swerdlow, Anthony J.
Visvanathan, Kala
Zeleniuch-Jacquotte, Anne
Liu, Mengling
author_sort Clendenen, Tess V.
collection PubMed
description BACKGROUND: Models that accurately predict risk of breast cancer are needed to help younger women make decisions about when to begin screening. Premenopausal concentrations of circulating anti-Müllerian hormone (AMH), a biomarker of ovarian reserve, and testosterone have been positively associated with breast cancer risk in prospective studies. We assessed whether adding AMH and/or testosterone to the Gail model improves its prediction performance for women aged 35–50. METHODS: In a nested case-control study including ten prospective cohorts (1762 invasive cases/1890 matched controls) with pre-diagnostic serum/plasma samples, we estimated relative risks (RR) for the biomarkers and Gail risk factors using conditional logistic regression and random-effects meta-analysis. Absolute risk models were developed using these RR estimates, attributable risk fractions calculated using the distributions of the risk factors in the cases from the consortium, and population-based incidence and mortality rates. The area under the receiver operating characteristic curve (AUC) was used to compare the discriminatory accuracy of the models with and without biomarkers. RESULTS: The AUC for invasive breast cancer including only the Gail risk factor variables was 55.3 (95% CI 53.4, 57.1). The AUC increased moderately with the addition of AMH (AUC 57.6, 95% CI 55.7, 59.5), testosterone (AUC 56.2, 95% CI 54.4, 58.1), or both (AUC 58.1, 95% CI 56.2, 59.9). The largest AUC improvement (4.0) was among women without a family history of breast cancer. CONCLUSIONS: AMH and testosterone moderately increase the discriminatory accuracy of the Gail model among women aged 35–50. We observed the largest AUC increase for women without a family history of breast cancer, the group that would benefit most from improved risk prediction because early screening is already recommended for women with a family history. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13058-019-1126-z) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6425605
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-64256052019-03-29 Breast cancer risk prediction in women aged 35–50 years: impact of including sex hormone concentrations in the Gail model Clendenen, Tess V. Ge, Wenzhen Koenig, Karen L. Afanasyeva, Yelena Agnoli, Claudia Brinton, Louise A. Darvishian, Farbod Dorgan, Joanne F. Eliassen, A. Heather Falk, Roni T. Hallmans, Göran Hankinson, Susan E. Hoffman-Bolton, Judith Key, Timothy J. Krogh, Vittorio Nichols, Hazel B. Sandler, Dale P. Schoemaker, Minouk J. Sluss, Patrick M. Sund, Malin Swerdlow, Anthony J. Visvanathan, Kala Zeleniuch-Jacquotte, Anne Liu, Mengling Breast Cancer Res Research Article BACKGROUND: Models that accurately predict risk of breast cancer are needed to help younger women make decisions about when to begin screening. Premenopausal concentrations of circulating anti-Müllerian hormone (AMH), a biomarker of ovarian reserve, and testosterone have been positively associated with breast cancer risk in prospective studies. We assessed whether adding AMH and/or testosterone to the Gail model improves its prediction performance for women aged 35–50. METHODS: In a nested case-control study including ten prospective cohorts (1762 invasive cases/1890 matched controls) with pre-diagnostic serum/plasma samples, we estimated relative risks (RR) for the biomarkers and Gail risk factors using conditional logistic regression and random-effects meta-analysis. Absolute risk models were developed using these RR estimates, attributable risk fractions calculated using the distributions of the risk factors in the cases from the consortium, and population-based incidence and mortality rates. The area under the receiver operating characteristic curve (AUC) was used to compare the discriminatory accuracy of the models with and without biomarkers. RESULTS: The AUC for invasive breast cancer including only the Gail risk factor variables was 55.3 (95% CI 53.4, 57.1). The AUC increased moderately with the addition of AMH (AUC 57.6, 95% CI 55.7, 59.5), testosterone (AUC 56.2, 95% CI 54.4, 58.1), or both (AUC 58.1, 95% CI 56.2, 59.9). The largest AUC improvement (4.0) was among women without a family history of breast cancer. CONCLUSIONS: AMH and testosterone moderately increase the discriminatory accuracy of the Gail model among women aged 35–50. We observed the largest AUC increase for women without a family history of breast cancer, the group that would benefit most from improved risk prediction because early screening is already recommended for women with a family history. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13058-019-1126-z) contains supplementary material, which is available to authorized users. BioMed Central 2019-03-19 2019 /pmc/articles/PMC6425605/ /pubmed/30890167 http://dx.doi.org/10.1186/s13058-019-1126-z Text en © The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Clendenen, Tess V.
Ge, Wenzhen
Koenig, Karen L.
Afanasyeva, Yelena
Agnoli, Claudia
Brinton, Louise A.
Darvishian, Farbod
Dorgan, Joanne F.
Eliassen, A. Heather
Falk, Roni T.
Hallmans, Göran
Hankinson, Susan E.
Hoffman-Bolton, Judith
Key, Timothy J.
Krogh, Vittorio
Nichols, Hazel B.
Sandler, Dale P.
Schoemaker, Minouk J.
Sluss, Patrick M.
Sund, Malin
Swerdlow, Anthony J.
Visvanathan, Kala
Zeleniuch-Jacquotte, Anne
Liu, Mengling
Breast cancer risk prediction in women aged 35–50 years: impact of including sex hormone concentrations in the Gail model
title Breast cancer risk prediction in women aged 35–50 years: impact of including sex hormone concentrations in the Gail model
title_full Breast cancer risk prediction in women aged 35–50 years: impact of including sex hormone concentrations in the Gail model
title_fullStr Breast cancer risk prediction in women aged 35–50 years: impact of including sex hormone concentrations in the Gail model
title_full_unstemmed Breast cancer risk prediction in women aged 35–50 years: impact of including sex hormone concentrations in the Gail model
title_short Breast cancer risk prediction in women aged 35–50 years: impact of including sex hormone concentrations in the Gail model
title_sort breast cancer risk prediction in women aged 35–50 years: impact of including sex hormone concentrations in the gail model
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6425605/
https://www.ncbi.nlm.nih.gov/pubmed/30890167
http://dx.doi.org/10.1186/s13058-019-1126-z
work_keys_str_mv AT clendenentessv breastcancerriskpredictioninwomenaged3550yearsimpactofincludingsexhormoneconcentrationsinthegailmodel
AT gewenzhen breastcancerriskpredictioninwomenaged3550yearsimpactofincludingsexhormoneconcentrationsinthegailmodel
AT koenigkarenl breastcancerriskpredictioninwomenaged3550yearsimpactofincludingsexhormoneconcentrationsinthegailmodel
AT afanasyevayelena breastcancerriskpredictioninwomenaged3550yearsimpactofincludingsexhormoneconcentrationsinthegailmodel
AT agnoliclaudia breastcancerriskpredictioninwomenaged3550yearsimpactofincludingsexhormoneconcentrationsinthegailmodel
AT brintonlouisea breastcancerriskpredictioninwomenaged3550yearsimpactofincludingsexhormoneconcentrationsinthegailmodel
AT darvishianfarbod breastcancerriskpredictioninwomenaged3550yearsimpactofincludingsexhormoneconcentrationsinthegailmodel
AT dorganjoannef breastcancerriskpredictioninwomenaged3550yearsimpactofincludingsexhormoneconcentrationsinthegailmodel
AT eliassenaheather breastcancerriskpredictioninwomenaged3550yearsimpactofincludingsexhormoneconcentrationsinthegailmodel
AT falkronit breastcancerriskpredictioninwomenaged3550yearsimpactofincludingsexhormoneconcentrationsinthegailmodel
AT hallmansgoran breastcancerriskpredictioninwomenaged3550yearsimpactofincludingsexhormoneconcentrationsinthegailmodel
AT hankinsonsusane breastcancerriskpredictioninwomenaged3550yearsimpactofincludingsexhormoneconcentrationsinthegailmodel
AT hoffmanboltonjudith breastcancerriskpredictioninwomenaged3550yearsimpactofincludingsexhormoneconcentrationsinthegailmodel
AT keytimothyj breastcancerriskpredictioninwomenaged3550yearsimpactofincludingsexhormoneconcentrationsinthegailmodel
AT kroghvittorio breastcancerriskpredictioninwomenaged3550yearsimpactofincludingsexhormoneconcentrationsinthegailmodel
AT nicholshazelb breastcancerriskpredictioninwomenaged3550yearsimpactofincludingsexhormoneconcentrationsinthegailmodel
AT sandlerdalep breastcancerriskpredictioninwomenaged3550yearsimpactofincludingsexhormoneconcentrationsinthegailmodel
AT schoemakerminoukj breastcancerriskpredictioninwomenaged3550yearsimpactofincludingsexhormoneconcentrationsinthegailmodel
AT slusspatrickm breastcancerriskpredictioninwomenaged3550yearsimpactofincludingsexhormoneconcentrationsinthegailmodel
AT sundmalin breastcancerriskpredictioninwomenaged3550yearsimpactofincludingsexhormoneconcentrationsinthegailmodel
AT swerdlowanthonyj breastcancerriskpredictioninwomenaged3550yearsimpactofincludingsexhormoneconcentrationsinthegailmodel
AT visvanathankala breastcancerriskpredictioninwomenaged3550yearsimpactofincludingsexhormoneconcentrationsinthegailmodel
AT zeleniuchjacquotteanne breastcancerriskpredictioninwomenaged3550yearsimpactofincludingsexhormoneconcentrationsinthegailmodel
AT liumengling breastcancerriskpredictioninwomenaged3550yearsimpactofincludingsexhormoneconcentrationsinthegailmodel